Skip to search formSkip to main contentSkip to account menu

Depo-Provera

Known as: depo-provera contraceptive, provera depo, DepoProvera 
National Institutes of Health

Related topics

Related topics

5 relations
1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe [Depo-Provera]Provera

Broader (3)

Medroxyprogesteronemedroxyprogesterone acetatemethylprednisolone acetate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Relative cost effectiveness of Depo-Provera®, Implanon®, and Mirena® in reversible long-term hormonal contraception in the UK
AbstractObjective: To estimate the relative cost effectiveness for women aged ≥30 years, starting long-term hormonal… 
Highly Cited
1998
Highly Cited
1998
Condom use by Hispanic and African-American adolescent girls who use hormonal contraception.
Highly Cited
1985
Highly Cited
1985
Long-acting contraceptive delivery systems.
In May 1983 some 115 participants representing 16 countries attended the International Workshop on Long-Acting Contraceptive… 
1985
1985
Effect of long-term hormonal contraception on plasma lipids.
Highly Cited
1980
Highly Cited
1980
Medroxyprogesterone acetate (depo‐provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma
A prospective trial was initiated in 1972 utilizing Depo‐Provera in women with metastatic or recurrent endometrial adenocarcinoma… 
1980
1980
Long-term contraception with Depo-Provera: a clinical evaluation.
Depo-Provera has been used as a long-acting injectable contraceptive. The results of the study carried out for more than 2 years… 
1979
1979
Blood levels of medroxyprogesterone acetate after multiple injections of depoprovera or cycloprovera.
1976
1976
A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive.
1972
1972
Lactation, conception, and the nutrition of the nursing mother and child.
Highly Cited
1971
Highly Cited
1971
Hormonal therapy in advanced renal cell carcinoma
A series of advanced renal cell carcinoma patients given clinical hormonal treatment is described. Eight cases (16.7%) showed… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)